Cancer medicines
Nivolumab
Nivolumab
A PD-1 inhibitor that supports anti-cancer immune responses.
Sources checked · Introductory guide
On this page
How it works
An immune checkpoint inhibitor that blocks the PD-1 pathway.[1]
Where it is used
Used alone or in combinations in selected lung, kidney and stomach cancer settings.[1]
Key safety points
Inflammation may affect bowel, lungs, liver or hormone organs. Report new breathlessness, diarrhea or jaundice promptly.[2]
Questions for your care team
- How do combination medicines change side effects and monitoring?
Sources and scope
Source documents are in English.
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.